Faron Pharmaceuticals Ltd. announced the appointment of Dr. Juho Jalkanen as director and Chief Executive Officer of the Company starting first of May 2024. Dr. Juho Markku Jalkanen (aged 46) currently serves as the Chief Operating Officer of Faron Pharmaceuticals since 2022 and has worked at Faron in various roles since 2006; as Deputy Member of the Board from 2006 to 2007, Director from 2013 to 2017 and Chief Development Officer from 2018. Dr Jalkanen worked at Turku University Hospital from 2008 to 2017, latterly as a Specialist Consultant in Vascular Surgery, having been a Medical General Practitioner (GP) from 2007 to 2008.

Dr. Jalkanen graduated from the University of Turku, Finland in 2005 with an MSc International Business Administration & Economics. During his studies he worked as a Researcher and conducted his Master's thesis concerning the Finnish Pharma Cluster. Dr. Jalkanen became MD in 2007 and obtained a PhD in Molecular Medicine and Vascular Surgery in 2017.

Current positions, directorships and/or partnerships: Inflames Pharma Oy; Kiinteistö Oy Pyhälinna. Former positions, directorships and/or partnerships (within the last five years): PharMart Oy, Piedino Financing Oy, Sisukas Limited.